Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 37

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 37
---
bioAffinity Technologies, Inc.

Consolidated Balance Sheets

    March 31, 2025  
    December 31, 2024 

     (unaudited)  

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $444,706  
    $1,105,291 
  
    Accounts and other receivables, net 
     963,744  
     1,139,204 
  
    Inventory 
     38,782  
     27,608 
  
    Prepaid expenses and other current assets 
     416,550  
     422,995 

    Total current assets 
     1,863,782  
     2,695,098 

    Non-current assets: 

    Property and equipment, net 
     382,409  
     375,385 
  
    Operating lease right-of-use asset, net 
     431,746  
     463,011 
  
    Finance lease right-of-use asset, net 
     684,629  
     780,872 
  
    Goodwill 
     1,404,486  
     1,404,486 
  
    Intangible assets, net 
     760,556  
     775,139 
  
    Other assets 
     19,675  
     19,676 

    Total assets 
    $5,547,283  
    $6,513,667 

    LIABILITIES AND STOCKHOLDERS’ EQUITY 

    Current liabilities: 

    Accounts payable 
    $1,381,578  
    $987,311 
  
    Accrued expenses 
     1,370,735  
     1,398,722 
  
    Unearned revenue 
     24,404  
     24,404 
  
    Operating lease liability, current portion 
     130,342  
     127,498 
  
    Finance lease liability, current portion 
     403,584  
     395,301 
  
    Notes payable, current portion 
     104,766  
     171,669 

    Total current liabilities 
     3,415,409  
     3,104,905 

    Non-current liabilities 

    Operating lease liability, net of current portion